The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias. According to a statement from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results